This Charles Schwab Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Avi Kapoor 1 year ago
NewsUpgradesMarketsAnalyst RatingsTrading Ideas
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Mitchell Kapoor upgraded the rating for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) from Sell to Neutral and maintained the price target of $75. Sarepta Therapeutics shares closed at $61.91 on Tuesday. See how other analysts view this stock.
- JP Morgan analyst Jimmy Bhullar upgraded Reinsurance Group of America, Incorporated (NYSE:RGA) from Neutral to Overweight and raised the price target from $232 to $237. Reinsurance Group shares closed at $198.27 on Tuesday. See how other analysts view this stock.
- Citigroup analyst Christopher Allen upgraded the rating for The Charles Schwab Corporation (NYSE:SCHW) from Neutral to Buy and lifted the price target from $85 to $102. Charles Schwab shares closed at $77.67 on Tuesday. See how other analysts view this stock.
- Goldman Sachs analyst Will Nance upgraded Fiserv, Inc. (NYSE:FI) from Neutral to Buy and raised the price target from $246 to $260. Fiserv shares closed at $222.01 on Tuesday. See how other analysts view this stock.
- Truist Securities analyst Bill Chappell upgraded The Scotts Miracle-Gro Company (NYSE:SMG) from Hold to Buy and maintained the price target of $70. Scotts Miracle Gro shares closed at $54.77 on Tuesday. See how other analysts view this stock.
Considering buying SCHW stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock